Trump was right, Germany was wrong — First on NATO, now on trade
The article discusses the ongoing debate over defense spending and pharmaceutical pricing between the U.S. and Europe. It highlights how President Trump was correct in urging European nations, particularly Germany, to contribute more to defense and innovation costs. The piece argues that the current pricing structures unfairly burden American consumers while benefiting European countries.
- ▪Ten years ago, Trump warned Europe about unsustainable defense spending, a message that was largely ignored until the Ukraine invasion.
- ▪Germany's strict controls on drug prices allow its citizens to pay less for medications, while Americans bear a disproportionate share of pharmaceutical innovation costs.
- ▪Trump's executive order on drug pricing could save the U.S. $529 billion over the next decade, but Germany is pushing for legislation to pay even less for innovative drugs.
Opening excerpt (first ~120 words) tap to expand
Ten years ago, President Donald Trump put Europe on notice, telling them the status quo on defense spending was unsustainable — and that America would not continue to shoulder the cost of keeping the European Union safe. Trump was right, but leaders like German Chancellor Olaf Scholz did not want to listen. Only after Russia’s 2022 invasion of Ukraine did they realize their mistake. Fast forward to 2026, and Scholz’s successor, Friedrich Merz, now aspires to command Europe’s largest army. Recommended Stories China is protecting its companies from EU attacks. Could the United States? Penn says it is fighting antisemitism. Its recent tenure decision tells another story The West needs a new strategy toward jihadist Iran regime It’s a significant acknowledgment that shows Trump was right.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Washington Examiner.
Discussion
0 commentsMore from Washington Examiner
